1. Home
  2. KLTO vs TRNR Comparison

KLTO vs TRNR Comparison

Compare KLTO & TRNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • TRNR
  • Stock Information
  • Founded
  • KLTO 2019
  • TRNR 2017
  • Country
  • KLTO United States
  • TRNR United States
  • Employees
  • KLTO N/A
  • TRNR N/A
  • Industry
  • KLTO
  • TRNR Consumer Electronics/Appliances
  • Sector
  • KLTO
  • TRNR Technology
  • Exchange
  • KLTO NYSE
  • TRNR Nasdaq
  • Market Cap
  • KLTO 7.1M
  • TRNR 6.8M
  • IPO Year
  • KLTO N/A
  • TRNR 2023
  • Fundamental
  • Price
  • KLTO $0.21
  • TRNR $0.88
  • Analyst Decision
  • KLTO
  • TRNR
  • Analyst Count
  • KLTO 0
  • TRNR 0
  • Target Price
  • KLTO N/A
  • TRNR N/A
  • AVG Volume (30 Days)
  • KLTO 35.4M
  • TRNR 1.3M
  • Earning Date
  • KLTO 05-15-2025
  • TRNR 05-19-2025
  • Dividend Yield
  • KLTO N/A
  • TRNR N/A
  • EPS Growth
  • KLTO N/A
  • TRNR N/A
  • EPS
  • KLTO N/A
  • TRNR N/A
  • Revenue
  • KLTO N/A
  • TRNR $6,373,000.00
  • Revenue This Year
  • KLTO N/A
  • TRNR $355.02
  • Revenue Next Year
  • KLTO N/A
  • TRNR N/A
  • P/E Ratio
  • KLTO N/A
  • TRNR N/A
  • Revenue Growth
  • KLTO N/A
  • TRNR 445.63
  • 52 Week Low
  • KLTO $0.11
  • TRNR $0.56
  • 52 Week High
  • KLTO $0.99
  • TRNR $850.00
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • TRNR 51.04
  • Support Level
  • KLTO N/A
  • TRNR $0.79
  • Resistance Level
  • KLTO N/A
  • TRNR $0.99
  • Average True Range (ATR)
  • KLTO 0.00
  • TRNR 0.09
  • MACD
  • KLTO 0.00
  • TRNR 0.01
  • Stochastic Oscillator
  • KLTO 0.00
  • TRNR 37.27

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About TRNR Interactive Strength Inc.

Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.

Share on Social Networks: